Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Frequent mutations of Fas gene in nasal NK/T cell lymphoma

Abstract

Fas (Apo-1/CD95) is a cell-surface receptor involved in cell death signaling through binding of Fas ligand. Mutation of Fas gene in lymphoid cells results in accumulation of these cells, which might thus contribute to lymphomagenesis. We examined the open reading frame of Fas cDNA in 14 cases of nasal NK/T-cell lymphoma. Mutations of Fas gene were detected in seven (50%) of 14 cases which comprised four frameshift, two missense, and one silent mutations. Frameshift mutations were caused by insertion of 1 bp (A) at nucleotide 1095 in two cases and by deletion of 1 bp at nucleotide 597 and at 704, respectively, in one each. Mouse T-cell lymphoma cells transfected with two missense mutated genes and frameshift mutations caused by insertion of 1 bp (A) at nucleotide 1095 were resistant to apoptosis induced by the anti-Fas antibody. These findings suggested that accumulation of lymphoid cells with Fas mutations provides a basis for the development of nasal NK/T-cell lymphoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Aozasa K, Yang WJ, Lee YB, Pan WS, Wy YF, Horiuchi K, Hyun BH, Tajima K . 1992 Int. J. Cancer 52: 673–674

  • Bertoni F, Conconi A, Luminari S, Realini C, Roggero E, Baldini L, Carobbio S, Cavalli F, Neri A, Zucca E . 2000 Leukemia 14: 446–448

  • Boldrini L, Faviana P, Pistolesi F, Gisfredi S, Di QD, Lucchi M, Mussi A, Angeletti CA, Baldinotti F, Fogli A, Simi P, Basolo F, Fontanini G . 2001 Oncogene 20: 6632–6637

  • Enno A, O'Rourke JL, Howlett CR, Jack A, Dixon MF, Lee A . 1995 Am. J. Pathol. 147: 217–222

  • Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hou JK, Guldberg P . 1998 Blood 92: 3018–3024

  • Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T . 1990 Lancet 335: 128–130

  • Holm LE, Blomgren H, Lowhagen T . 1985 N. Engl. J. Med. 312: 601–604

  • Hongyo T, Li T, Syaifudin M, Baskar R, Ikeda H, Kanakura Y, Aozasa K, Nomura T . 2000 Cancer Res. 60: 2345–2347

  • Itoh N, Nagata S . 1993 J. Biol. Chem. 268: 10932–10937

  • Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S . 1991 Cell 66: 233–243

  • Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC . 1996 Am. J. Surg. Pathol. 20: 103–111

  • Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, Tominaga S . 1985 Jpn. J. Cancer Res. 76: 1085–1090

  • Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS . 1997 Blood 90: 4266–4270

  • Lee SH, Shin MS, Park WS, Kim SY, Dong SM, Pi JH, Lee HK, Kim HS, Jang JJ, Kim CS, Kim SH, Lee JY, Yoo NJ . 1999a Cancer Res. 59: 3068–3072

  • Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ . 1999b Oncogene 18: 3754–3760

  • Li T, Hongyo T, Syaifudin M, Nomura T, Dong Z, Shingu N, Kojya S, Nakatsuka S, Aozasa K . 2000 Lab. Invest. 80: 493–499

  • Malkhosyan S, Rampino N, Yamamoto H, Perucho M . 1996 Nature 382: 499–500

  • Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B . 1995 Science 268: 1336–1338

  • Mizushima S, Nagata S . 1990 Nucleic Acids Res. 18: 5322

  • Muschen M, Re D, Brauninger A, Wolf J, Hansmann ML, Diehl V, Kuppers R, Rajewsky K . 2000 Cancer Res. 60: 5640–5643

  • Ng CS, Lo ST, Chan JK . 1999 Hum. Pathol. 30: 48–53

  • Ohsawa M, Nakatsuka S, Kanno H, Miwa H, Kojya S, Harabuchi Y, Yang WI, Aozasa K . 1999 Int. J. Cancer 81: 865–870

  • Park WS, Oh RR, Kim YS, Park JY, Lee SH, Shin MS, Kim SY, Kim PJ, Lee HK, Yoo NY, Lee JY . 2001 J. Pathol. 193: 162–168

  • Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5548–5550

  • Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M . 1997 Science 275: 967–969

  • Seeberger H, Starostik P, Schwarz S, Knorr C, Kalla J, Ott G, Muller HH, Greiner A . 2001 Lab. Invest. 81: 977–986

  • Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YQ, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ . 1996 Nat. Genet. 14: 255–257

  • Suda T, Takahashi T, Golstein P, Nagata S . 1993 Cell 75: 1169–1178

  • Takakuwa T, Dong Z, Takayama H, Matsuzuka F, Nagata S, Aozasa K . 2001 Cancer Res. 61: 1382–1385

  • Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ . 1992 Blood 79: 1789–1795

  • Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG . 1993 Lancet 342: 575–577

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katsuyuki Aozasa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takakuwa, T., Dong, Z., Nakatsuka, S. et al. Frequent mutations of Fas gene in nasal NK/T cell lymphoma. Oncogene 21, 4702–4705 (2002). https://doi.org/10.1038/sj.onc.1205571

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205571

Keywords

This article is cited by

Search

Quick links